← Leaderboards
Jeffrey Rappaport
Thomas Jefferson University
$187,904
Attributed
$187,904
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48K · FY2018–22$50K$37.5K$25K$12.5K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$187,904 · 1
By mechanism
F30$187,904 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Linda D Siracusa$6,139,882
- Scott A. Waldman$27,830,994
- Bruce M Boman$1,068,921
- Philip N Tsichlis$14,961,127
- Erik Blomain$130,062
Others in their field
Other Emerging Leaders on “Epithelial”
- Gary Fanger · Rise Therapeutics, Llc$15,902,290
- Jakob H. Von Moltke · University Of Washington$8,146,800
- Shruti Naik · New York University School Of Medicine$6,937,612
- Birgit Schilling · Medical College Of Wisconsin$6,423,173
- Nicholas Arpaia · Columbia Univ New York Morningside$6,241,249
- Elizabeth Ann Sugar · Johns Hopkins University$6,179,197
Research focus
EpithelialEventAgonistApicalArchitectureAutomobile DrivingBeta CateninCancer CellCancer ChemopreventionCancer EtiologyCancer PreventionCell ModelCellsChemopreventive AgentChronicColon CarcinomaColorectalColorectal CancerColorectal Cancer PreventionColorectal Cancer TreatmentConstipationDna DamageDna Sequence AlterationFamily
Grant awards (4)
Restoring Guanylin-Guanylate cyclase C Signaling to Prevent Colorectal Cancer$48,020
F30 · FY2022 · CA · contact PI
Restoring Guanylin-Guanylate cyclase C Signaling to Prevent Colorectal Cancer$47,304
F30 · FY2021 · CA · contact PI
Restoring Guanylin-Guanylate cyclase C Signaling to Prevent Colorectal Cancer$46,788
F30 · FY2020 · CA · contact PI
Restoring Guanylin-Guanylate cyclase C Signaling to Prevent Colorectal Cancer$45,792
F30 · FY2018 · CA · contact PI